Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$444,660
+$214,136 QoQ
Shares Held
72,657
+117.8% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 172 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Derivatives in VNDA
reported options exposure · as of Jun 30, 2020CallValue
$0
CallShares
0
PutValue
$0
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $457,365,908 across 219 Biotechnology names. VNDA ranks #127 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in VNDA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $444,660 | 72,657 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $230,524 | 33,361 | Shares | Sole | 2026-05-12 | |
| 2021-06-30 ALXN | — | 1,931 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 ALXN | — | 3,341 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 ALXN | — | 13,394 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 ALXN | — | 13,070 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 ALXN | — | 500 | Put | Sole | 2020-07-23 | |
| 2020-06-30 ALXN | — | 12,257 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 ALXN | — | 12,970 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||